Balchem Corp
BCPC
View Detailed Chart
173.160USD
-0.560-0.32%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
5.61BMarket Cap
37.56P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.32%
5 Days
+1.76%
1 Month
+10.99%
6 Months
+8.22%
Year to Date
+12.91%
1 Year
+5.36%
View Detailed Chart
TradingKey Stock Score of Balchem Corp
Currency: USD Updated: 2026-02-06Key Insights
Balchem Corp's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 11 out of 69 in the Chemicals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 191.00.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Balchem Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Balchem Corp Highlights
StrengthsRisks
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 953.68M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 22.16%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 22.16%.
Fairly Valued
The company’s latest PB is 4.32, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 30.08M shares, increasing 0.06% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 191.00 shares of this stock.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
191.000
Target Price
+9.95%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Balchem Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Balchem Corp Info
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Ticker SymbolBCPC
CompanyBalchem Corp
CEOHarris (Theodore L)
Website
Related Instruments
-2.49%
+0.26%
+1.09%
-0.13%
+0.18%
+0.93%
+1.68%
+3.86%
+4.40%
+2.26%
+1.61%
+1.45%
+4.08%
+2.16%
+0.93%
+3.03%
+1.77%
+6.97%
+0.06%
+1.29%Popular Symbols
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
68595.320
-1374.810 (-1.97%)
282.580
+22.390 (+8.61%)
2038.240
-13.490 (-0.66%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
